李冰馨, 傅深. The related mechanism of radiotherapy in triple-negative breast cancer[J]. China Oncology, 2014, 24(11): 865-870. DOI: 10.3969/j.issn.1007-3969.2014.11.012.
The related mechanism of radiotherapy in triple-negative breast cancer
放射治疗是乳腺癌局部治疗的主要手段之一。三阴性乳腺癌(triple-negative breast cancer,TNBC)作为乳腺癌分子亚型的一个分型,其分子及生物学行为具有多方面特殊性,并存在多个分子靶点的异常,这些异常分子靶点可通过不同机制影响肿瘤对电离辐射的反应,从而调节三阴性乳腺癌的放疗敏感性。现就TNBC的放射治疗及其放疗敏感性相关分子靶点的研究新进展予以综述。
Abstract
Radiotherapy is one of the main means of local treatment of breast cancer. Triple negative breast cancer (TNBC) as a molecular subtypes of breast cancer
its biological behavior is special and existing multiple molecular targets
these molecular targets influence the response of ionization radiation through different mechanisms and regulate radiotherapy sensitivity of TNBC This article reviewed the recent advances in radiotherapy and radiosensitivity related molecular targets of TNBC.
Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study
TIPE regulates glucometabolic reprogramming by modulating LDHA expression in triple-negative breast cancer
Current status and prospects of tertiary lymphoid structure heterogeneity in predicting response to neoadjuvant therapy and characterizing immune microenvironment in triple-negative breast cancer
The progress of treatment for brain metastases of triple-negative breast cancer
Advancements in the research of immunomodulatory effects of radiation therapy: from basic to clinical
Related Author
Ximei ZHANG
Yixuan ZHOU
Yan ZHAO
Xuan ZHOU
Xudong WANG
Yingbin YAN
Peiguo WANG
Wei HU
Related Institution
Department of Maxillofacial Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
Tianjin Key Laboratory of Oral and Maxillofacial Functional Reconstruction
Department of Oral and Maxillofacial-Head and Neck Surgery, Tianjin Stomatological Hospital Affiliated to Nankai University School of Medicine
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
Tianjin Clinical Research Center for Malignant Tumors